fda glp-1 compounding crackdown october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA issued 25 warning letters
Description
Fortunately, at Regain, our medical weight loss treatments dont end after the consultation
The trend gets stronger when it sits beside meals, water, protein, symptoms, and the weekly shot
If you are dealing with the GLP-1 headache side effect, know you are not alone and help is available
Even a small appetite dip can keep 150200 calories off your plate each day
If you are tracking your protein intake on semaglutide , this single smoothie covers roughly 40% of most daily targets
